Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.37 USD | -1.44% | +1.48% | +17.09% |
13/05 | HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating | MT |
09/05 | Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.09% | 10Cr | |
+8.38% | 11TCr | |
+10.13% | 10TCr | |
+1.31% | 2.26TCr | |
-11.69% | 2.25TCr | |
-11.07% | 1.8TCr | |
-41.90% | 1.65TCr | |
-16.00% | 1.58TCr | |
+2.28% | 1.35TCr | |
+20.54% | 1.1TCr |
- Stock Market
- Equities
- CLSD Stock
- News Clearside Biomedical, Inc.
- Insider Trends: Insider Buying Extended with Purchase of Clearside Biomedical Shares